Search Results - Karsten Spiekermann
- Showing 1 - 2 results of 2
-
1
Clonal hematopoiesis in AML long‐term survivors: Risk factors and clinical consequences by Simon M. Krauß, Eva Telzerow, Daniel Richter, Anna S. Moret, Maja Rothenberg‐Thurley, Cristina Sauerland, Anne Weigert, Alessia Fraccaroli, Johanna Tischer, Frank Ziemann, Katharina S. Götze, Wolfgang E. Berdel, Bernhard Wörmann, Utz Krug, Jan Braess, Pia Heussner, Wolfgang Enard, Wolfgang Hiddemann, Karsten Spiekermann, Dennis Görlich, Uwe Platzbecker, Klaus H. Metzeler
Published 2025-07-01
Article -
2
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups by Ricarda Knabe, Philippe Muller, Christoph Schliemann, Maher Hanoun, Julia Marie Unglaub, Barbora Weinbergerová, Jiří Mayer, Carolin Krekeler, Stefan W. Krause, Martin Kaufmann, Sabrina Kraus, Björn Steffen, Franziska Modemann, Marion Subklewe, Veit Bücklein, Wolfgang G. Kunz, Martina Rudelius, Michael von Bergwelt-Baildon, Katja Gutmair, Eva Hoster, Tobias Herold, Christoph Röllig, Karsten Spiekermann
Published 2025-07-01
Article